An interventional study of Altitude exposure in Effects of High Altitude, sponsored by University of Zurich. Completed at 1 site in Kyrgyzstan. Open to participants aged 20 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-10-30.
Sponsored by University of Zurich · Not applicable, Interventional, and Basic science
The study evaluates respiratory acclimatization in healthy lowlanders staying for 3 weeks at 3200 m.
This study evaluates the effect of 3 weeks altitude acclimatization on sleep related breathing disturbances in healthy subjects staying at 3200 m. Participants living in Bishkek, Kyrgyzstan (700 m), will be transferred by car within 4 h to the Tuja Ashu high altitude clinic (3200 m). Outcomes will be assessed repeatedly during the stay at 3200 m.
189 studies on the registry are indexed under Altitude Sickness; 44 are open to participants now.
This study's enrollment of 20 is below the median of 33 across 157 interventional studies indexed under Altitude Sickness.
Browse Altitude Sickness studies →University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Stay at 3200 m for 3 weeks
Other: Altitude exposure
Participants will stay for 3 weeks at an altitude of 3200 m
Mean nocturnal oxygen saturation measured by pulse oximetry
Difference in mean nocturnal oxygen saturation between night 1 and night 7
Time frame: night 7 at 3200 m
Mean nocturnal oxygen saturation measured by pulse oximetry
Difference in mean nocturnal oxygen saturation between night 1 at 3200 and night 1 at 700 m
Time frame: night 1 at 3200 m
Mean nocturnal oxygen saturation measured by pulse oximetry
Difference in mean nocturnal oxygen saturation between night 21 and night 1 at 3200 m
Time frame: night 21 at 3200 m
Mean nocturnal oxygen saturation measured by pulse oximetry
Mean nocturnal oxygen saturation during night 1 at 700 m
Time frame: night 1 at 700 m (low altitude baseline)
This study is completed, as verified in Oct 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Zurich